Angiogenesis in cancer and other diseases
Top Cited Papers
- 14 September 2000
- journal article
- review article
- Published by Springer Nature in Nature
- Vol. 407 (6801) , 249-257
- https://doi.org/10.1038/35025220
Abstract
Pathological angiogenesis is a hallmark of cancer and various ischaemic and inflammatory diseases. Concentrated efforts in this area of research are leading to the discovery of a growing number of pro- and anti-angiogenic molecules, some of which are already in clinical trials. The complex interactions among these molecules and how they affect vascular structure and function in different environments are now beginning to be elucidated. This integrated understanding is leading to the development of a number of exciting and bold approaches to treat cancer and other diseases. But owing to several unanswered questions, caution is needed.Keywords
This publication has 57 references indexed in Scilit:
- Stem cell therapy and gene transfer for regenerationGene Therapy, 2000
- Transgenic mouse models in angiogenesis and cardiovascular diseaseThe Journal of Pathology, 2000
- The Hallmarks of CancerCell, 2000
- Controlling the cellular brakesNature, 1999
- Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularizationJournal of Clinical Investigation, 1999
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996
- Hypoxic stress proteins: Survival of the fittestSeminars in Radiation Oncology, 1996
- Modulation of the Organ Microenvironment for Treatment of Cancer MetastasisJNCI Journal of the National Cancer Institute, 1995
- Angiogenic activity of adipose tissueBiochemical and Biophysical Research Communications, 1988
- THE GROWTH OF MALIGNANT DISEASE IN MAN AND THE LOWER ANIMALS,: WITH SPECIAL REFERENCE TO THE VASCULAR SYSTEMThe Lancet, 1907